#United States #New York #Class Action #Gross Law Firm #Alto Neuroscience

Gross Law Firm Alert: Alto Neuroscience Shareholders

On July 31, 2025, the Gross Law Firm issued a critical notice to shareholders of Alto Neuroscience, Inc. (NYSE: ANRO), reminding them of an impending deadline related to a class action lawsuit. This announcement is particularly important for those who acquired shares during the specified class period from the firm's initial public offering on February 2, 2024, to October 22, 2024.

Shareholders Advised to Participate

The law firm encourages these shareholders to reach out regarding potential lead plaintiff appointments, emphasizing that being appointed as a lead plaintiff is not a requirement for participation in any recovery. This initiative aims to safeguard investors' interests who may have incurred financial losses due to misleading statements made by the company.

Allegations Against Alto Neuroscience

The lawsuit claims that Alto Neuroscience may have misrepresented vital information concerning its product pipeline, particularly concerning the efficacy of ALTO-100, a treatment for major depressive disorder. Allegations state that the defendants overstated ALTO-100’s clinical effectiveness, leading shareholders to assume a falsely rosy picture of the company's business and financial health. Consequently, the lawsuit avows that this misrepresentation resulted in an inflated stock price, which later negatively impacted shareholders once the truth was revealed.

Important Deadlines

September 19, 2025 marks the deadline for shareholders to register for this class action lawsuit. The Gross Law Firm emphasizes the urgency, advising affected shareholders to act promptly to ensure their rights are protected. Registration is also said to include automatic updates through a portfolio monitoring software throughout the litigation process, which can help shareholders stay informed about the case’s progress.

Why Choose Gross Law Firm

Regarded as a well-respected national class action law firm, Gross Law Firm operates with a commitment to defending investors' rights against deceitful business practices. Their team is devoted to enforcing ethical corporate conduct, aiding investors in seeking recovery from the damages incurred by false representation or the omission of material facts regarding a company’s financial state. It's important to note that the firm operates on a no-cost basis for participation in the class action. If you believe you may be affected, now is the time to register your interest with the firm.

Contact Information

Those interested can reach the Gross Law Firm at their New York office at 15 West 38th Street, 12th floor, New York, NY 10018, or via email at [email protected]. Direct phone inquiries can be made at (646) 453-8903.

In summary, the Gross Law Firm's notice serves as a crucial reminder for Alto Neuroscience shareholders to participate in an essential legal process aimed at holding the company accountable for its purported misdeeds and restoring investor confidence.